Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,107Revenue (TTM) $M12,311Net Margin (%)9.2Altman Z-Score2.8
Enterprise Value $M47,973EPS (TTM) $5.3Operating Margin %13.2Piotroski F-Score6
P/E(ttm)34.1Beneish M-Score-2.7Pre-tax Margin (%)10.2Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %6.3Quick Ratio1.1Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %2.4Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow20.3y-y EBITDA Growth Rate %34.4ROA % (ttm)4.3Higher Current Ratio y-yY
Dividend Yield %1.5PEG14.3ROE % (ttm)15.2Less Shares Outstanding y-yN
Payout Ratio %49.0Shares Outstanding M213ROIC % (ttm)8.1Gross Margin Increase y-yY

Gurus Latest Trades with BDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDXFirst Eagle Investment 2016-06-30 Reduce-0.39%$151.82 - $172.19
($163.71)
$ 178.979%Reduce -71.89%390,407
BDXVanguard Health Care Fund 2016-06-30 Reduce-0.28%$151.82 - $172.19
($163.71)
$ 178.979%Reduce -30.89%1,868,387
BDXRobert Olstein 2016-06-30 Reduce-0.16%$151.82 - $172.19
($163.71)
$ 178.979%Reduce -14.81%46,000
BDXT Rowe Price Equity Income Fund 2016-06-30 Add0.1%$151.82 - $172.19
($163.71)
$ 178.979%Add 17.47%860,000
BDXMario Gabelli 2016-06-30 Reduce-0.03%$151.82 - $172.19
($163.71)
$ 178.979%Reduce -14.77%162,864
BDXDodge & Cox 2016-06-30 Reduce$151.82 - $172.19
($163.71)
$ 178.979%Reduce -7.37%13,830
BDXKen Fisher 2016-06-30 Reduce$151.82 - $172.19
($163.71)
$ 178.979%Reduce -5.30%1,395
BDXJoel Greenblatt 2016-06-30 Reduce$151.82 - $172.19
($163.71)
$ 178.979%Reduce -4.40%18,713
BDXT Rowe Price Equity Income Fund 2016-03-31 Add0.27%$132.88 - $154.09
($145.43)
$ 178.9723%Add 104.61%732,099
BDXRobert Olstein 2016-03-31 Reduce-0.22%$132.88 - $154.09
($145.43)
$ 178.9723%Reduce -16.92%54,000
BDXJoel Greenblatt 2016-03-31 Reduce-0.1%$132.88 - $154.09
($145.43)
$ 178.9723%Reduce -75.23%19,575
BDXVanguard Health Care Fund 2016-03-31 Reduce-0.07%$132.88 - $154.09
($145.43)
$ 178.9723%Reduce -7.97%2,703,387
BDXMario Gabelli 2016-03-31 Reduce-0.02%$132.88 - $154.09
($145.43)
$ 178.9723%Reduce -11.10%191,090
BDXFirst Eagle Investment 2016-03-31 Add0.01%$132.88 - $154.09
($145.43)
$ 178.9723%Add 1.15%1,389,002
BDXKen Fisher 2016-03-31 Reduce$132.88 - $154.09
($145.43)
$ 178.9723%Reduce -47.64%1,473
BDXDodge & Cox 2016-03-31 Add$132.88 - $154.09
($145.43)
$ 178.9723%Add 1.01%14,930
BDXRichard Pzena 2015-12-31 Sold Out -0.32%$134.59 - $156.53
($147.95)
$ 178.9721%Sold Out0
BDXJoel Greenblatt 2015-12-31 Buy 0.13%$134.59 - $156.53
($147.95)
$ 178.9721%New holding79,016
BDXT Rowe Price Equity Income Fund 2015-12-31 Add0.1%$134.59 - $156.53
($147.79)
$ 178.9721%Add 70.38%357,800
BDXMario Gabelli 2015-12-31 Reduce-0.04%$134.59 - $156.53
($147.95)
$ 178.9721%Reduce -18.09%214,955
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Tharby Linda MExecutive Vice President 2016-09-06Sell11,704$177.27-0.15view
COHEN GARY MExecutive Vice President 2016-08-11Sell29,367$176.810.11view
Gallagher John EVP, Corp Finance and Treasurer 2016-06-13Sell1,931$169.874.2view
Shabshab NabilExecutive Vice President 2016-06-07Sell5,080$168.754.89view
SHERMAN JEFFREY SSr. VP and General Counsel 2016-05-17Sell34,373$166.276.46view
FORLENZA VINCENT AChairman, CEO and President 2016-05-13Sell37,933$166.176.52view
Sichak StephenExecutive Vice President 2016-05-13Sell12,995$166.486.33view
ORR JAMES FDirector 2016-05-10Sell1,368$167.665.58view
Lim James CExecutive Vice President 2016-05-09Sell5,257$165.66.89view
Conroy AlexandreExecutive Vice President 2016-05-09Sell11,238$165.586.9view

Press Releases about BDX :

Quarterly/Annual Reports about BDX:

News about BDX:

Articles On GuruFocus.com
The 10 Best Dividend Aristocrats Aug 15 2016 
Vanguard Sold Shares in 7 of Top 10 Quarterly Transactions Aug 02 2016 
Mawer Investment Newsletter 2nd Quarter 2016 Jul 15 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Bearish Sentiment in Becton Dickinson's Stock Apr 27 2016 
Weekly 52-Week Highs Highlights Apr 27 2016 
Mario Gabelli Sells Alphabet, AT&T Mar 17 2016 
Richard Pzena Buys Chevron During 4th Quarter Feb 10 2016 
Mawer Investment Newsletter 4th Quarter 2015 Jan 25 2016 
A Recession-Resistant Dividend Aristocrat With 10% Dividend Growth Jan 05 2016 

More From Other Websites
These 5 Rocket Stocks Are Ready for Blastoff Sep 26 2016
Twilio Inc (TWLO), Alphabet Inc (GOOGL) and More: These 5 Stocks Are Dominating the Charts Sep 23 2016
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility Sep 23 2016
Becton Dickinson downgraded by Citigroup Sep 23 2016
Becton, Dickinson (BDX) Launch Wireless Diagnostic Device Sep 22 2016
BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing Sep 22 2016
BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing Sep 22 2016
BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device Sep 21 2016
BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device Sep 21 2016
Becton, Dickinson & Co. – Value Analysis (NYSE:BDX) : September 19, 2016 Sep 19 2016
Becton, Dickinson (BDX) Introduces New Vascular Dressing Sep 19 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test Sep 17 2016
ETF’s with exposure to Becton, Dickinson & Co. : September 16, 2016 Sep 16 2016
Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : September... Sep 16 2016
BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial Sep 16 2016
BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial Sep 16 2016
Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX Sep 15 2016
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions Sep 14 2016
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions Sep 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)